AI assistant
Robertet — Interim / Quarterly Report 2025
Sep 25, 2025
1630_ir_2025-09-25_9a4ec636-d8c1-43f8-a74a-4bfdc9a5b941.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
{0}------------------------------------------------

{1}------------------------------------------------
CONTENTS
| FIRST-HALF 2025 MANAGEMENT REPORT 3 |
|---|
| — |
| CONSOLIDATED FINANCIAL STATEMENTS 7 |
| Consolidated statement of income |
| Consolidated statement of comprehensive income |
| Consolidated statement of financial position |
| Consolidated statement of changes in equity |
| Consolidated statement of cash flows |
| — |
| NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS 13 |
| — |
| STATUTORY AUDITORS' REVIEW REPORT ON THE HALF-YEARLY FINANCIAL INFORMATION 31 |
| — |
| STATEMENT BY THE PERSONS RESPONSIBLE FOR THE INTERIM FINANCIAL REPORT 33 |
{2}------------------------------------------------
FIRST-HALF 2025 MANAGEMENT REPORT
Six months ended June 30, 2025

{3}------------------------------------------------

FIRST-HALF 2025 MANAGEMENT REPORT
CONTEXT
In first-half 2025, Robertet continued to fulfill its mission of "Futuring naturals", and delivered an excellent performance.
In an instable and uncertain environment, Robertet continues to draw on its major assets: its expertise in naturals, its agility towards its customers, and the stability of its family shareholder structure.
The geopolitical context remains a cause for concern, creating a prudent, wait-and-see attitude. The flow of goods is disrupted, tariffs are increasing and customers are exercising caution when it comes to inventories.
The effects of currency fluctuations are notable and have been and on the rise for several months, generating a widening gap between our organic performance and reported growth. Nevertheless, inflation and interest rates are declining, there are a number of projects in the pipeline for the launch of new products, and certain regions are showing good momentum.
In the first half of 2025, Robertet recorded revenue of €446.3 million, representing growth of 7.7%, or 7.1% on a constant scope basis. On a comparable exchange rate and scope basis, organic growth came out at 9.2%. In the first quarter of 2025, revenue rose by 5.5% compared with the same period in 2024. Growth picked up further in the second quarter, with revenue up 10.0% on the same period last year.
RESULTS BY DIVISION
The solid first-half 2025 performance mainly reflects strong growth in the Flavors and Raw Materials Divisions, but all Robertet Divisions reported growth during the period.
Raw Materials accounted for 26.3% of revenue, up 14.4%, driven by solid momentum in the fine fragrances market, a slight upturn in the aromatherapy market in the United States and robust demand from customers in Europe and Asia. The Division has represented Robertet's unique expertise for 175 years, and offers its customers a unique catalog of over 1,600 natural products from more than 60 countries.
{4}------------------------------------------------
Fragrances accounted for 35.8% of revenue, up 0.5%, driven by modest growth in Europe and strong growth in South America, the Middle East and Asia. However, the Division was held back by the slowdown in North America attributable to inventory effects at one of our main customers. The Fragrances Division continues to expand sharply with niche brands, including in North America, and in growth markets such as China, Brazil and the Middle East.
The Flavors Division represented 35.3% of revenue, up 10.7%, benefiting from customers seeking natural solutions and unique creations. Demand is strong from both large global customers and regional customers looking for local or original tastes.
Health & Beauty, which accounted for 2.6% of revenue, grew 9.1% over the period. The Division is pursuing its commercial development on the three major continents of Europe, North America and Asia. Its clinically-proven natural active ingredients are winning over dietary supplement brands, as well as beverage and cosmetics brands.
RESULTS BY REGION
Results were driven by strong growth in Europe, Asia and South America, but were stable in North America.
Europe accounted for 48% of Group revenue, with strong double-digit growth across all Divisions and countries. Natural raw materials benefited from a healthy performance for fine fragrances and the upturn of organic products. Flavors saw strong momentum with a number of major international customers.
North America accounted for 34% of Group revenue and delivered very slight organic growth of 0.6%. All Divisions reported robust growth, with the exception of fragrances, which had to contend with significant inventory reductions at a major customer. The rest of the Division continued to grow sharply, with a proactive drive to win new projects. We remain optimistic going forward thanks to our loyal customers comprising major international customers, and our ability to support emerging brands targeting younger generations. During the period we expanded our Creative Center in New York. Our strong local manufacturing footprint is supporting business levels, but price negotiations to reflect new tariffs on our raw materials are currently ongoing.
Latin America accounted for 7% of revenue and is enjoying strong growth. It continues to expand across all countries and Divisions, with fragrances experiencing particularly strong growth in Brazil and Mexico. We continue to gain ground in this region, with high levels of demand from both regional and international groups and brands.
North Asia accounted for 5% of revenue, with strong growth in China and Japan. Raw materials and fragrances are driving this growth, thanks in particular to young, dynamic local brands. China offers great potential for raw materials and fragrances thanks to the growing number of local brands and their increasingly premium positioning. Meanwhile, we are strengthening our organization in the flavors business to ensure that we return to growth.
South Asia and India accounted for 6% of revenue, reporting growth compared with the prior-year period, particularly in Indonesia and in fragrances. The region is a thriving hub of regional family-owned groups looking for original products as well as agile, responsive partners. The acquisition of Sonarome at the end of 2023 gave us a strong foothold in flavors in India, while we are currently building our first production facility in Indonesia to enhance our positioning in this strategic country.
FINANCIAL PERFORMANCE
Recurring EBITDA came to €100.2 million, up 12.7% on the first half of 2024, representing 22.5% of revenue. The improvement in gross margin was due to lower purchase prices and a favorable product mix within our categories.
Recurring operating income grew by 17.0% to €85.2 million. However, it was marked by significant rises in external expenses linked to our major IT projects, as well as higher transportation, travel and personnel costs linked to business growth.
Consolidated net income came to €59 million, up 13.1% compared with the first half of 2024, representing 13.2% of revenue. Lower interest rates led to lower returns on our cash investments as well as a lower cost of debt, resulting in a favorable net finance cost.
{5}------------------------------------------------

SIGNIFICANT EVENTS
Following the arrival of new shareholders in November 2024, the Board of Directors welcomed four new members: two new independent members representing the two new reference shareholders, Fonds Stratégique de Placement and Peugeot Invest Assets, who will support Robertet's future development; and two new directors from the Maubert family, reaffirming the family's long ‑term commitment to Robertet and its desire to remain independent .
Robertet is pursuing a targeted acquisitions strategy with the acquisition of the entire share capital of Phasex in the United States at the end of 2024. The company, which is currently being integrated, provides our North American subsidiary Robertet USA with the capacity to extract American ingredients for the local market. This expertise in the extraction of new technology raw materials will be a key strength in serving our local customers and positioning Robertet as an expert in naturals.
Non-financial performance is also a priority, with a record 64 certified sourcing channels, while water consumption and CO 2 emissions are decreasing. We have also set up an ethics committee to promote a sustainable business climate among our internal and external stakeholders. During the period, we were awarded a Ecovadis Platinum medal and continued to improve our EthiFinance score, demonstrating performance of our teams across all these sustainable development issues.
Robertet is strengthening its global presence by investing in its industrial capacity in Indonesia and Mexico, as well as opening new creative centers to host our customers and our creative and sales teams. At the start of 2025, we doubled our presence in New York and Dubai and inaugurated our new creative centers in Shanghai, Singapore and Mexico City.
Our Grasse-based start-up accelerator – dedicated to natural products – is enjoying strong success, with nearly 20 resident companies benefiting from our support in developing their projects and products and accessing the market and financing. Embodying our vertical "Seed to Scent" business model, these start-ups are pioneering the naturals of the future, proving each day the enduring appeal and resilience of natural products .
We are also continuing to invest heavily in our industrial facilities and IT systems, and in expanding our premises and workforce to prepare for future growth.
Our solid first-half 2025 revenue performance supports our organic revenue growth objective for full-year 2025, in line with our 2030 targets, i.e., growth of between 5% and 7%.
JÉRÔME BRUHAT
Chief Executive Officer
{6}------------------------------------------------
CONSOLIDATED FINANCIAL STATEMENTS
Six months ended June 30, 2025

{7}------------------------------------------------
CONSOLIDATED STATEMENT OF INCOME
| In thousands of euros | Note | June 30, 2024 |
Dec. 31, 2024 |
June 30, 2025 |
|---|---|---|---|---|
| Revenue | 12 | 414,579 | 807,609 | 446,337 |
| REVENUE FROM ORDINARY ACTIVITIES | 414,579 | 807,609 | 446,337 | |
| Other operating income | 14 | 3,788 | 4,820 | 3,216 |
| Purchases used in production | (179,628) | (352,422) | (182,054) | |
| External charges | (57,676) | (116,628) | (65,108) | |
| Personnel costs | (87,136) | (177,856) | (97,539) | |
| Taxes other than on income | (5,009) | (8,457) | (4,629) | |
| Additions to/reversals from depreciation, amortization and provisions | 13 | (15,334) | (31,242) | (14,498) |
| Impairment of trade receivables, other receivables and contract assets | 13 | (690) | (450) | (449) |
| Other operating expenses | 14 | (86) | (117) | (88) |
| RECURRING OPERATING INCOME | 12 | 72,808 | 125,256 | 85,187 |
| Asset disposals | 243 | (162) | (49) | |
| OPERATING INCOME | 73,052 | 125,094 | 85,138 | |
| Share of net income of companies accounted for by the equity method | 221 | 380 | 279 | |
| OPERATING INCOME AFTER SHARE OF NET INCOME OF COMPANIES ACCOUNTED FOR BY THE EQUITY METHOD |
73,272 | 125,474 | 85,417 | |
| Income from cash and cash equivalents | 2,914 | 5,649 | 2,410 | |
| Gross cost of debt | (6,432) | (11,350) | (4,749) | |
| Net finance costs | 15 | (3,519) | (5,701) | (2,339) |
| Other financial income and expenses | 15 | (702) | 1351 | (3,354) |
| INCOME BEFORE TAX | 69,052 | 121,124 | 79,724 | |
| Current and deferred taxes | 16 | (16,907) | (30,545) | (20,743) |
| CONSOLIDATED NET INCOME | 52,145 | 90,580 | 58,981 | |
| Net income attributable to non-controlling interests | 456 | 511 | 480 | |
| NET INCOME (attributable to owners of the company) | 12 | 51,688 | 90,068 | 58,501 |
| Basic earnings per share (in euros) | 18 | 24.71 | 43.06 | 28.55 |
| Diluted earnings per share (in euros) | 18 | 24.71 | 43.06 | 28.55 |
{8}------------------------------------------------
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
| In thousands of euros | Note | June 30, 2024 |
Dec. 31, 2024 |
June 30, 2025 |
|---|---|---|---|---|
| CONSOLIDATED NET INCOME | 52,145 | 90,580 | 58,981 | |
| Items that may be reclassified to income | 6,349 | 10,159 | (34,002) | |
| Change in foreign currency translation adjustments | SCIE1 | 5,882 | 11,127 | (33,881) |
| Interest rate swaps | 630 | (1,304) | (164) | |
| Tax on interest rate swaps | (163) | 337 | 42 | |
| Items that will not be reclassified to income | 168 | 62 | 59 | |
| Remeasurement of the net defined benefit liability (asset) | 9 | 246 | 84 | 80 |
| Tax on remeasurement of the net defined benefit liability (asset) | (78) | (23) | (21) | |
| TOTAL COMPREHENSIVE INCOME | SCIE1 | 58,662 | 100,800 | 25,038 |
| Attributable to Robertet SA shareholders | SCIE1 | 58,192 | 100,252 | 24,794 |
| Attributable to non-controlling interests | SCIE1 | 470 | 548 | 244 |
1 SCIE: Consolidated statement of changes in equity.
{9}------------------------------------------------
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
| In thousands of euros | Note | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|---|
| NON-CURRENT ASSETS | 389,994 | 389,857 | |
| Goodwill | 3 | 83,154 | 82,290 |
| Intangible assets | 4.1 | 78,773 | 76,681 |
| Property, plant and equipment | 4.2 | 178,252 | 173,446 |
| Right-of-use assets | 4.3 | 22,885 | 22,213 |
| Financial assets | 5 | 16,417 | 25,621 |
| Investments in associates | 3,768 | 3,877 | |
| Deferred taxes | 16 | 6,744 | 5,730 |
| CURRENT ASSETS | 618,192 | 617,642 | |
| Inventories and work in progress | 6 | 239,958 | 238,291 |
| Trade receivables | 7 | 155,994 | 180,173 |
| Other receivables and accruals | 8 | 22,826 | 27,718 |
| Current tax assets | 8 | 3,069 | 3,631 |
| Other current financial assets | 35,334 | 18,356 | |
| Cash and cash equivalents | 17 | 158,133 | 146,637 |
| Assets held for sale | 2,878 | 2,836 | |
| TOTAL ASSETS | 1,008,186 | 1,007,499 | |
| EQUITY | 552,112 | 557,438 | |
| Share capital | 5,764 | 5,423 | |
| Share premium | 67,218 | 67,218 | |
| Consolidated reserves | 478,824 | 484,797 | |
| Equity (attributable to owners of the Company) | 551,805 | 557,438 | |
| Non-controlling interests | 307 | - | |
| NON-CURRENT LIABILITIES | 257,511 | 254,241 | |
| Non-current provisions | 9 | 792 | 1,209 |
| Non-current employee benefits | 9 | 11,353 | 11,439 |
| Non-current financial liabilities | 10.1 | 201,182 | 197,147 |
| Non-current lease liabilities | 10.2 | 18,337 | 17,737 |
| Deferred taxes | 16 | 25,847 | 26,709 |
| CURRENT LIABILITIES | 198,562 | 195,820 | |
| Current provisions | 9 | 1,852 | 1,674 |
| Current employee benefits | 9 | 1,386 | 1,472 |
| Current financial liabilities | 10.1 | 66,111 | 65,773 |
| Current lease liabilities | 10.2 | 5,526 | 5,445 |
| Current tax liabilities | 10,449 | 3,893 | |
| Trade payables | 62,867 | 67,394 | |
| Other current liabilities | 11 | 47,494 | 47,333 |
| Liabilities held for sale | 2,879 | 2,836 | |
| TOTAL EQUITY AND LIABILITIES | 1,008,186 | 1,007,499 |
{10}------------------------------------------------
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
| In thousands of euros | Share capital |
Share premium |
Consolidated reserves |
Cumulative foreign currency translation adjustments |
Own shares |
Equity attributable to owners of the Company |
Non controlling interests |
Total equity |
|---|---|---|---|---|---|---|---|---|
| BALANCE AT DECEMBER 31, 20231 |
5,764 | 61,945 | 603,247 | (1,238) | (204,031) | 465,687 | 906 | 466,593 |
| Net income | 51,688 | 51,688 | 456 | 52,145 | ||||
| Other comprehensive income | 644 | 5,860 | 6,503 | 14 | 6,517 | |||
| Total comprehensive income | 52,332 | 5,860 | 58,192 | 470 | 58,662 | |||
| Dividends paid | (17,779) | (17,779) | - | (17,779) | ||||
| Transactions with non controlling interests and changes in liabilities for put options over minority interests2 |
(1,967) | (1,967) | 51 | (1,916) | ||||
| Allocation of free shares | 1,314 | 1,314 | - | 1,314 | ||||
| Other movements | 5,273 | (4,867) | 406 | - | 406 | |||
| Total other movements in equity |
5,273 | (23,299) | (18,026) | 51 | (17,976) | |||
| BALANCE AT JUNE 30, 2024 |
5,764 | 67,218 | 632,280 | 4,622 | (204,031) | 505,853 | 1,427 | 507,280 |
| BALANCE AT DECEMBER 31, 2024 |
5,764 | 67,218 | 673,002 | 9,852 | (204,031) | 551,805 | 307 | 552,112 |
| Net income | 58,501 | 58,501 | 480 | 58,981 | ||||
| Other comprehensive income | (62) | (33,644) | (33,707) | (237) | (33,943) | |||
| Total comprehensive income | 58,438 | (33,644) | 24,794 | 244 | 25,038 | |||
| Dividends paid | (20,960) | (20,960) | (20,960) | |||||
| Transactions with non controlling interests and changes in liabilities for put options over minority interests3 |
417 | 417 | (551) | (133) | ||||
| Allocation of free shares | 1,056 | 1,056 | 1,056 | |||||
| Capital reduction | (341) | 341 | ||||||
| Other movements | 326 | 326 | 326 | |||||
| Total other movements in equity |
(341) | (19,161) | 341 | (19,161) | (551) | (19,712) | ||
| BALANCE AT JUNE 30, 2025 |
5,423 | 67,218 | 712,279 | (23,792) | (203,690) | 557,438 | - | 557,438 |
(1) Amounts reported in the 2023 consolidated financial statements as of December 31, 2023, restated to reflect the retrospective application of provisional goodwill relating to the Sonarome business combination.
(2) Transactions with non-controlling interests in first-half 2024 mainly concerned:
• the change in fair value of the put option on minority interests representing 40% of the capital of Astier Demarest, for a negative impact of €1,677 thousand;
• the change in fair value of the put option on minority interests representing 15% of the capital of Sonarome, for a negative impact of €124 thousand.
(3) Transactions with non-controlling interests in first-half 2025 mainly concerned:
• the acquisition of shares in Robertet Group Indonesia, increasing the Robertet Group's stake from 67% to 100%, for a negative impact of €133 thousand.
{11}------------------------------------------------
CONSOLIDATED STATEMENT OF CASH FLOWS
| In thousands of euros | Note | June 30, 2024 |
Dec. 31, 2024 |
June 30, 2025 |
|---|---|---|---|---|
| Consolidated net income | 12 | 51,688 | 90,068 | 58,501 |
| Net income attributable to non-controlling interests | 456 | 511 | 480 | |
| Elimination of net income of companies accounted for by the equity method | (71) | (230) | (109) | |
| Depreciation and amortization | 13 | 13,301 | 24,601 | 14,419 |
| Net additions to provisions | 1,486 | 2,899 | 700 | |
| (Gain)/Loss on disposal of assets | (243) | 162 | 49 | |
| Income and expenses with no cash impact | 2,187 | 2,167 | 1,056 | |
| Income tax expense (current and deferred taxes) | 16 | 16,864 | 30,479 | 20,747 |
| Net cost of debt | 3,293 | 1,953 | 1,439 | |
| Effect of hyperinflation | 385 | 1,108 | 39 | |
| Cash flow from operations before net cost of debt and income tax | 89,348 | 153,718 | 97,321 | |
| Interest paid | (6,439) | (11,499) | (4,850) | |
| Interest received | 3,140 | 9,396 | 3,306 | |
| Income tax paid | (14,676) | (29,776) | (26,573) | |
| Cash flow from operations after net cost of debt and income tax | 71,372 | 121,839 | 69,204 | |
| Change in inventories | 6 | 2,999 | (6,176) | (9,955) |
| Change in trade and other receivables | 7 | (38,796) | (15,394) | (36,068) |
| Change in trade and other payables | 10,488 | 12,145 | 9,524 | |
| Impact of change in working capital | 17 | (25,310) | (9,425) | (36,499) |
| NET CASH FROM OPERATING ACTIVITIES | 46,063 | 112,414 | 32,706 | |
| Industrial investments | 4 | (15,613) | (38,595) | (16,894) |
| Financial investments | (8,277) | (6,379) | 303 | |
| Asset disposals | 9,242 | 11,972 | 3,444 | |
| Acquisition of subsidiaries, net of cash acquired | (16) | (5,330) | (2,089) | |
| NET CASH USED IN INVESTING ACTIVITIES | (14,663) | (38,333) | (15,236) | |
| Dividends paid by the parent company | SCIE1 | (17,779) | (17,779) | (20,960) |
| Proceeds from new borrowings | 6,236 | 10,203 | 5,091 | |
| Repayments of borrowings | (6,431) | (52,623) | (10,656) | |
| Increase in other financial liabilities | 3,546 | 7,581 | 6,156 | |
| Decrease in other financial liabilities | (2,534) | (6,312) | (1,775) | |
| NET CASH USED IN FINANCING ACTIVITIES | (16,963) | (58,930) | (22,145) | |
| IMPACT OF CURRENCY FLUCTUATIONS ON CASH AND CASH EQUIVALENTS |
533 | 1,480 | (8,264) | |
| NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS |
14,969 | 16,630 | (12,940) | |
| Net cash at beginning of period | 139,280 | 139,280 | 155,910 | |
| Net cash at end of period | 17 | 154,249 | 155,910 | 142,970 |
1 SCIE: Consolidated statement of changes in equity.
{12}------------------------------------------------
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Six months ended June 30, 2025

{13}------------------------------------------------
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 – GENERAL INFORMATION, SIGNIFICANT EVENTS OF THE PERIOD AND EVENTS AFTER THE REPORTING DATE
1.1. General information
The Robertet Group's condensed consolidated financial statements for the first half of 2025 include Robertet SA, the parent company, and its subsidiaries. Robertet, also referred to as "the Group", specializes in the creation, production and distribution of aromatic products intended mainly for the fragrances and food industries.
Robertet SA, the parent company (also referred to as "the Company") is a public limited company (société anonyme) incorporated under French law, and is listed on the Paris Stock Exchange (Euronext compartment B). Its head office is located at 37 avenue Sidi Brahim in Grasse.
The condensed consolidated financial statements for the first half of 2025 were approved for issue by the Board of Directors on September 10, 2025.
1.2 Significant events of the period
On January 4, 2025, Robertet Africa merged with Robertet SA via a universal asset transfer. Robertet SA generated a merger bonus of €301 thousand, which was allocated in full to financial income.
On February 26, 2025, Robertet SA reduced its share capital from €5,763,972.50 to €5,423,242.50 by cancelling 136,292 treasury shares, representing €340,730.00.
1.3. Events after the reporting date
No significant events that would alter the disclosures in these financial statements occurred between the reporting date, as of June 30, 2025, and the date of the Board of Directors' meeting at which these financial statements were approved for issue, on September 10, 2025.
A process to put the Sirius entity up for sale was launched in July 2024 and was still ongoing at the reporting date.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
2.1. Basis of preparation of the consolidated financial statements
Because it is listed in a European Union country, in accordance with EC regulation 1606/2002 of July 19, 2002, the Robertet Group's consolidated financial statements have been prepared and published in accordance with International Financial Reporting Standards (IFRS), as adopted by the European Union. These include the IFRS approved by the International Accounting Standards Board (IASB), the International Accounting Standards (IAS) and the interpretations issued by the International Financial Reporting Interpretations Committee (IFRIC).
The condensed interim consolidated financial statements at June 30, 2025 were prepared in accordance with IAS 34 – Interim Financial Reporting. Pursuant to IAS 34, only a selection of explanatory notes is included in these condensed financial statements. These notes should be read in conjunction with the consolidated financial statements for the year ended December 31, 2024. The accounting policies are identical to those applied for said consolidated financial statements.
For the presentation of the condensed interim consolidated financial statements for the period ended June 30, 2025, the Group has applied the following new standards and interpretations which have been adopted by the European Union and whose application was mandatory for the first-time for annual financial periods beginning on or after January 1, 2025:
Standards, amendments and interpretations with mandatory application from January 1, 2025
• Amendment to IAS 21 – The Effects of Changes in Foreign Exchange Rates: Lack of Exchangeability, issued on August 15, 2023.
These new standards and amendments did not have a material impact on the Group's consolidated financial statements.
Standards, amendments and interpretations not yet applicable at January 1, 2025
- Amendments to IFRS 9 and IFRS 7 Amendments to the Classification and Measurement of Financial Instruments, issued by the IASB on May 30, 2024.
- Amendments to IFRS 9 and IFRS 7 Contracts Referencing Nature-dependent Electricity, issued by the IASB on December 18, 2024.
- Annual improvements to IFRS 1, IFRS 7, IFRS 9, IFRS 10 and IAS 7, published by the IASB on July 18, 2024.
- IFRS 18 Presentation and Disclosure in Financial Statements, published by the IASB on April 9, 2024.
- IFRS 19 Subsidiaries without Public Accountability: Disclosures, published by the IASB on May 9, 2024.
{14}------------------------------------------------
The Group has chosen not to early adopt these standards and amendments, but has begun to analyze the impacts of their application. The Group will apply these standards in its financial statements once they have been adopted by the European Union.
2.2. Use of estimates
The preparation of financial statements in accordance with IFRS requires the use of estimates and assumptions that affect the amounts reported in the financial statements. The main areas where estimates and assumptions are used are the methods applied to identify and measure intangible assets in business combinations, impairment of non-financial assets, employee benefits, provisions for contingencies, impairment of inventories and receivables, and determining the lease term and lease payments included in calculating lease liabilities.
These estimates are based on the best information available to Management at the reporting date. Changes in estimates and assumptions could have an impact on the amounts recognized in the financial statements.
2.3. Consolidation methods
In accordance with IFRS 10, the Group's consolidated financial statements include the accounts of all companies directly or indirectly controlled by Robertet SA, regardless of its level of ownership in their equity and the accounts of all associates or companies over which it exercises significant influence.
Subsidiaries (controlled companies) are fully consolidated. Companies over which Robertet SA exercises joint control or significant influence are accounted for using the equity method.
Shares in companies that do not meet these criteria are recorded as equity investments.
Intercompany receivables, payables, income and expenses are eliminated in full on consolidation, as are gains and losses on intercompany transactions (dividends, capital gains and losses, inventory margins, etc.).
All of the companies included in the Group's consolidated financial statements have a June 30 period-end.
The financial statements of foreign entities whose functional currency is not the euro are translated into euros at the period-end exchange rate, and their income statements and cash flow statements are translated at the average exchange rate for the period. The related translation gains or losses are recorded in other comprehensive income under foreign currency translation adjustments within "Consolidated reserves".
Under IAS 29, Argentina and Turkey have been on the list of hyperinflationary economies since 2018 and 2022, respectively.
Pursuant to this standard, the following accounting treatment has been applied to the financial statements of Group subsidiaries operating in these countries:
- non-monetary balance sheet items are restated by applying a general price index;
- statement of income and comprehensive income items in local currency are restated by applying the change in the general price index from the initial recording of income and expense items in the financial statements;
- the balance sheet, statement of income and statement of comprehensive income are translated into euros at the period-end exchange rate;
- the restatement of reserves for the indexation of equity items of subsidiaries in these countries are included in "Change in foreign currency translation adjustments" in the statement of comprehensive income.
2.4. Description of the principal risks and uncertainties for the second half of 2025
The risk factors relating to the Group's business segment and human resources, financial and environmental risks are of the same nature as those set out in the management report included in the 2024 Annual Financial Report and have not changed significantly over the first half of 2025.
2.5. Transactions with related parties
Information on related parties is provided in note 19, which presents the main developments during the period.
{15}------------------------------------------------
NOTE 3 – GOODWILL
Goodwill recognized in the statement of financial position breaks down as follows:
| In thousands of euros | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|
| FLAVORS DIVISION | ||
| Gross value | 37,424 | 37,424 |
| Impairment | ||
| Net value | 37,424 | 37,424 |
| FRAGRANCES DIVISION | ||
| Gross value | 17,808 | 17,808 |
| Impairment | ||
| Net value | 17,808 | 17,808 |
| RAW MATERIALS DIVISION | ||
| Gross value | 23,534 | 22,669 |
| Impairment | ||
| Net value | 23,534 | 22,669 |
| HEALTH & BEAUTY DIVISION | ||
| Gross value | 4,389 | 4,389 |
| Impairment | ||
| Net value | 4,389 | 4,389 |
| TOTAL NET VALUE | 83,154 | 82,290 |
Changes in the net values of goodwill can be analyzed as follows:
| In thousands of euros | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|
| Net carrying amount at beginning of period | 81,517 | 83,154 |
| Acquisitions | 1,346 | |
| Translation adjustments | 291 | (865) |
| TOTAL | 83,154 | 82,290 |
An analysis of goodwill did not indicate any impairment at June 30, 2025.
{16}------------------------------------------------
NOTE 4 – INTANGIBLE ASSETS, PROPERTY, PLANT AND EQUIPMENT AND RIGHT-OF-USE ASSETS
4.1. INTANGIBLE ASSETS
| Intangible assets (in thousands of euros) |
Value at Dec. 31, 2024 |
Translation adjustments |
Acquisitions | Disposals | Other movements |
Value at June 30, 2025 |
|---|---|---|---|---|---|---|
| Gross value | 93,293 | (2,108) | 1,901 | (13) | (11) | 93,062 |
| Amortization (in thousands of euros) |
Value at Dec. 31, 2024 |
Translation adjustments |
Additions | Reversals | Other movements |
Value at June 30, 2025 |
| Amortization | 14,520 | (581) | 2,510 | (12) | (57) | 16,381 |
| NET VALUE | 78,773 | 76,681 | ||||
| Intangible assets (in thousands of euros) |
Value at Dec. 31, 20231 |
Translation adjustments |
Acquisitions | Disposals | Other movements |
Value at June 30, 2024 |
| Gross value | 88,753 | 805 | 278 | - | 3,008 | 92,844 |
| Amortization (in thousands of euros) |
Value at Dec. 31, 2023 |
Translation adjustments |
Additions | Reversals | Other movements |
Value at June 30, 2024 |
| Amortization | 8,837 | 57 | 2,352 | - | 1,144 | 12,390 |
1 Amounts reported in the consolidated financial statements as of December 31, 2023, restated to reflect the retrospective application of provisional goodwill relating to the Sonarome business combination.
4.2. PROPERTY, PLANT AND EQUIPMENT
| Property, plant and equipment (in thousands of euros) |
Value at Dec. 31, 2024 |
Translation adjustments |
Acquisitions | Disposals | Other movements |
Value at June 30, 2025 |
|---|---|---|---|---|---|---|
| Land and improvements | 32,251 | (697) | 68 | 31,622 | ||
| Buildings | 200,179 | (8,864) | 6,231 | (52) | 197,493 | |
| Technical installations | 183,564 | (6,981) | 4,279 | (458) | 503 | 180,908 |
| Other PPE | 41,533 | (2,713) | 726 | (186) | 62 | 39,422 |
| Assets in progress |
23,563 | (545) | (525) | 165 | 22,658 | |
| TOTAL | 481,090 | (19,800) | 10,710 | (643) | 746 | 472,103 |
{17}------------------------------------------------
| Depreciation (in thousands of euros) |
Value at Dec. 31, 2024 |
Translation adjustments |
Additions | Reversals | Other movements |
Value at June 30, 2025 |
|---|---|---|---|---|---|---|
| Land and improvements |
4,379 | (33) | 163 | 5 | 4,514 | |
| Buildings | 108,239 | (4,720) | 3,378 | 59 | 106,956 | |
| Technical installations | 154,237 | (5,653) | 4,026 | (337) | 272 | 152,546 |
| Other PPE | 35,982 | (2,273) | 1,105 | (193) | 19 | 34,641 |
| TOTAL | 302,838 | (12,679) | 8,672 | (530) | 356 | 298,657 |
| NET VALUE | 178,252 | 173,446 |
| Property, plant and equipment (in thousands of euros) |
Value at Dec. 31, 20231 |
Translation adjustments |
Acquisitions | Disposals | Other movements |
Value at June 30, 2024 |
|---|---|---|---|---|---|---|
| Land and improvements |
31,962 | (115) | 48 | 490 | 32,385 | |
| Buildings | 193,845 | 1,404 | 1,496 | (27) | 82 | 196,799 |
| Technical installations | 194,310 | 1,082 | 2,346 | (39) | (21,519) | 176,179 |
| Other PPE | 21,064 | 335 | 315 | (64) | 19,209 | 40,859 |
| Assets in progress |
7,813 | 63 | 4,988 | (232) | 12,632 | |
| TOTAL | 448,993 | 2,769 | 9,193 | (130) | (1,971) | 458,854 |
| Depreciation (in thousands of euros) |
Value at Dec. 31, 2023 |
Translation adjustments |
Additions | Reversals | Other movements |
Value at June 30, 2024 |
|---|---|---|---|---|---|---|
| Land and improvements |
4,092 | 222 | 5 | 4,320 | ||
| Buildings | 100,424 | 972 | 3,091 | (27) | 430 | 104,891 |
| Technical installations | 162,829 | 1,071 | 3,517 | (38) | (17,092) | 150,287 |
| Other PPE | 16,944 | 349 | 1,718 | (35) | 16,076 | 35,052 |
| TOTAL | 284,290 | 2,393 | 8,548 | (100) | (580) | 294,550 |
| NET VALUE | 164,703 | 164,304 |
1 Amounts reported in the consolidated financial statements as of December 31, 2023, restated to reflect the retrospective application of provisional goodwill relating to the Sonarome business combination.
{18}------------------------------------------------
4.3. RIGHT-OF-USE ASSETS
Movements in right-of-use assets in first-half 2024 and 2025 can be analyzed as follows:
| Right-of-use assets (in thousands of euros) |
Value at Dec. 31, 2024 |
Translation adjustments |
Acquisitions | Disposals | Other movements |
Value at June 30, 2025 |
|---|---|---|---|---|---|---|
| Buildings | 32,399 | (2,350) | 2,544 | (789) | (87) | 31,717 |
| Technical installations | 10,908 | (930) | 1,009 | (84) | 10,903 | |
| Other PPE | 8,176 | (188) | 729 | (754) | 7,963 | |
| TOTAL | 51,483 | (3,468) | 4,282 | (1,543) | (170) | 50,584 |
| Depreciation (in thousands of euros) |
Value at Dec. 31, 2024 |
Translation adjustments |
Additions | Reversals | Other movements |
Value at June 30, 2025 |
|---|---|---|---|---|---|---|
| Buildings | 16,924 | (1,180) | 2,139 | (707) | (123) | 17,053 |
| Technical installations | 6,644 | (533) | 301 | (84) | 6,328 | |
| Other PPE | 5,030 | (114) | 797 | (699) | (24) | 4,990 |
| TOTAL | 28,598 | (1,827) | 3,237 | (1,406) | (231) | 28,371 |
| NET VALUE | 22,885 | 22,213 |
| Right-of-use assets (in thousands of euros) |
Value at Dec. 31, 2023 |
Translation adjustments |
Acquisitions | Disposals | Other movements |
Value at June 30, 2024 |
|---|---|---|---|---|---|---|
| Buildings | 21,221 | (67) | 5,521 | (30) | 54 | 26,700 |
| Technical installations | 13,115 | 231 | 333 | (2) | (12) | 13,665 |
| Other PPE | 8,330 | 9 | 571 | (431) | 56 | 8,534 |
| TOTAL | 42,667 | 173 | 6,425 | (463) | 98 | 48,899 |
| Depreciation (in thousands of euros) |
Value at Dec. 31, 2023 |
Translation adjustments |
Additions | Reversals | Other movements |
Value at June 30, 2024 |
|---|---|---|---|---|---|---|
| Buildings | 14,390 | (126) | 1,370 | (30) | 54 | 15,657 |
| Technical installations | 8,746 | 133 | 289 | (2) | (12) | 9,154 |
| Other PPE | 4,912 | 16 | 677 | (431) | 56 | 5,229 |
| TOTAL | 28,048 | 22 | 2,335 | (463) | 98 | 30,040 |
| NET VALUE | 14,619 | 18,859 |
The residual expense for lease payments at June 30, 2025 was €1.7 million (versus €1.1 million at June 30, 2024) and corresponds to payments under leases that are not recorded in the statement of financial position in accordance with the accounting principles and exemptions provided for in IFRS 16.
{19}------------------------------------------------
NOTE 5 – NON-CURRENT FINANCIAL ASSETS
| In thousands of euros | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|
| Equity investments | 2,890 | 2,948 |
| Receivables related to equity investments | 5,219 | 4,760 |
| Other long-term investments1 | 1,093 | 11,146 |
| Loans | 45 | 61 |
| Other financial assets | 7,170 | 6,707 |
| TOTAL | 16,417 | 25,621 |
1 Corresponding to long-term investments of the American subsidiary Robertet USA Inc.
NOTE 6 – INVENTORIES
Inventories can be analyzed as follows:
| In thousands of euros | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|
| Raw materials | 162,289 | 158,482 |
| Work in progress and finished goods | 85,329 | 87,313 |
| Gross value | 247,618 | 245,796 |
| Impairment | (7,660) | (7,505) |
| NET VALUE | 239,958 | 238,291 |
Impairment losses can be analyzed as follows:
| In thousands of euros | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|
| AT BEGINNING OF PERIOD | 8,069 | 7,660 |
| Increases | 4,918 | 3,376 |
| Reversals and utilizations | (3,606) | (3,448) |
| Translation adjustments | 120 | (575) |
| Other movements | (1,841) | 492 |
| AT END OF PERIOD | 7,660 | 7,505 |
{20}------------------------------------------------
NOTE 7 – TRADE RECEIVABLES
Trade receivables break down by geographical area as follows:
| In thousands of euros | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|
| Europe | 58,568 | 74,351 |
| North America | 49,044 | 59,073 |
| South America | 18,703 | 14,450 |
| Asia | 25,979 | 27,546 |
| Other countries | 13,400 | 14,645 |
| TOTAL GROSS RECEIVABLES | 165,694 | 190,066 |
| Impairment | (9,700) | (9,892) |
| TOTAL NET RECEIVABLES | 155,994 | 180,173 |
Impairment of trade receivables can be analyzed as follows:
| In thousands of euros | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|
| AT BEGINNING OF PERIOD | 9,643 | 9,700 |
| Increases | 1,335 | 657 |
| Changes in scope of consolidation | 13 | - |
| Reversals and utilizations | (1,261) | (208) |
| Translation adjustments | - | (147) |
| Other movements | (29) | (111) |
| AT END OF PERIOD | 9,700 | 9,892 |
NOTE 8 – OTHER CURRENT ASSETS
Other current assets break down as follows:
| In thousands of euros | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|
| Prepaid expenses | 6,096 | 9,659 |
| Other receivables | 16,730 | 18,059 |
| Total other receivables and accruals | 22,826 | 27,718 |
| Current tax assets | 3,069 | 3,631 |
| TOTAL | 25,895 | 31,348 |
{21}------------------------------------------------
NOTE 9 – PROVISIONS AND EMPLOYEE BENEFITS
| In thousands of euros | At beginning of period |
Additions | Utilizations | Changes in exchange rates |
Other movements |
At end of period |
|---|---|---|---|---|---|---|
| Retirement benefits1 | 9,667 | 358 | (97) | (5) | 9,923 | |
| Other employee benefit obligations2 | 3,071 | 114 | (108) | (89) | 2,988 | |
| Other risks3 | 2,644 | 724 | (467) | (18) | 2,883 | |
| TOTAL PROVISIONS AND EMPLOYEE BENEFITS |
15,382 | 1,196 | (575) | (204) | (5) | 15,794 |
| Of which current liabilities | 3,237 | 3,146 | ||||
| Of which recorded in non-current liabilities |
12,145 | 12,648 |
1 The Group contributes to constituting pensions for its employees in accordance with the laws and practices of the countries in which its companies operate. It also has certain contractual obligations for supplementary pensions, statutory retirement bonuses and personal risk insurance. The corresponding actuarial liabilities are assumed either in the form of contributions paid to independent organizations responsible for managing and servicing the funds, or in the form of provisions.
Since provisions for retirement benefits in France represent 92.1% of the Group's total provisions, only the discount rates applied to the Group's obligations in France are detailed below. They are determined based on the yield on investment-grade corporate bonds (AA10+ Iboxx index) at the period-end, i.e., 3.45%.
| June 30, 2024 | Dec. 31, 2024 | June 30, 2025 | |
|---|---|---|---|
| Discount rate | 3.60% | 3.35% | 3.45% |
NOTE 10 – FINANCIAL LIABILITIES
10.1 FINANCIAL LIABILITIES
| Analysis by type of liability (in thousands of euros) | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|
| Bank borrowings | 240,327 | 236,961 |
| Bank overdrafts | 2,223 | 3,666 |
| Other financial liabilities1 | 23,158 | 19,629 |
| Shareholder current accounts | 1,585 | 2,663 |
| TOTAL | 267,293 | 262,920 |
1 At the end of the period, other financial liabilities included:
- A financial liability of €2,200 thousand in respect of a put option on 10% of the capital of Astier Demarest, exercisable on December 31, 2027 (financial liability of €2,106 thousand at December 31, 2024).
- A financial liability of €2,492 thousand in respect of the acquisition of the Maverick Group (Omega Ingredients) in 2022, related to an earn-out clause (financial liability of €5,634 thousand at December 31, 2024).
- A financial liability of €9,885 thousand in respect of a put option on 15% of the capital of Sonarome, put in place on December 1, 2023 (financial liability of €10,572 thousand at December 31, 2024).
2 Other employee benefit obligations mainly correspond to a provision for retirement benefits for the Mexican entity, which must be paid to any employee leaving the company except in the event of resignation. Payment of these severance benefits to an employee who is dismissed by the company constitutes a settlement agreement.
3 Other risks mainly correspond to employee-related, tax and commercial risks. Each known dispute in which Robertet or Group companies are involved was examined at the reporting date and, based on the advice of legal counsel, the provisions deemed necessary were set aside to cover the estimated risks.
{22}------------------------------------------------
The breakdown between fixed and variable rate borrowings is as follows (considering the use of hedging instruments):
| In thousands of euros | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|
| Fixed-rate borrowings | 132,839 | 133,259 |
| Variable-rate borrowings | 107,488 | 103,702 |
| TOTAL | 240,327 | 236,961 |
| Analysis by repayment schedule and by currency (in thousands of euros) |
Dec. 31, 2024 | June 30, 2025 |
|---|---|---|
| Less than one year | 66,111 | 65,773 |
| Between one and five years |
185,568 | 183,142 |
| Beyond five years | 15,614 | 14,005 |
| TOTAL | 267,293 | 262,920 |
| Of which in euros | 234,319 | 237,545 |
| Of which in US dollars | 14,149 | 11,914 |
| Of which in other currencies | 18,825 | 13,461 |
The breakdown of borrowings due in less than one year is as follows:
| Breakdown of current liabilities (in thousands of euros) | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|
| Current portion of borrowings | 60,044 | 59,438 |
| Current portion of other financial liabilities | 3,843 | 2,668 |
| Bank overdrafts | 2,223 | 3,666 |
| TOTAL | 66,111 | 65,773 |
Repayments of borrowings in the first half of 2025 amounted to €10,656 thousand, compared with €6,431 thousand in the first half of 2024 and €52,623 thousand in full-year 2024. Proceeds from new borrowings amounted to €5,091 thousand. Certain borrowings taken out by the parent company and Robertet USA Inc. are subject to covenants.
For Robertet SA, these borrowings represented an amount of €187,261 thousand at the end of the period. The consolidated EBITDA/consolidated net debt ratios set out in the covenants were complied with. In addition, three swaps are in place to hedge these borrowings: the first was set up in September 2022 and covered 50% of the simplified public offering loan at a fixed rate of 2.605%. The second was set up on June 14, 2024 and covered 50% of the loan linked to the Sonarome acquisition at a fixed rate of 2.95%.The third was set up on August 1, 2024 to extend financial coverage to 75% of the simplified public offering loan and 75% of the loan linked to the Sonarome acquisition at a fixed rate of 2.65%.
Lastly, Robertet USA Inc. has a loan with the US bank PNC Bank, which is subject to covenants. The outstanding principal stood at \$8.1 million (€6.9 million) at the period-end. At June 30, 2025, the entity was compliant with the leverage and debt service coverage ratios stipulated in the contract.
{23}------------------------------------------------
10.2. LEASE LIABILITIES
This item corresponds to the Group's financial liabilities arising on all of its leases recognized in accordance with IFRS 16.
| In thousands of euros |
At beginning of period |
New contracts and renewals |
Repayments and cancellations |
Changes in scope of consolidation and other movements |
Translation adjustments |
At end of period |
|---|---|---|---|---|---|---|
| Lease liabilities | 23,863 | 4,134 | (3,133) | 56 | (1,739) | 23,181 |
| Of which current liabilities |
5,526 | 5,445 | ||||
| Of which non-current liabilities |
18,337 | 17,737 |
| Analysis by repayment schedule (in thousands of euros) | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|
| Due in less than one year | 5,526 | 5,445 |
| Due in between one and five years | 12,256 | 12,188 |
| Due in more than five years | 6,081 | 5,549 |
| TOTAL | 23,863 | 23,181 |
| Of which in euros | 4,363 | 4,676 |
| Of which in US dollars | 11,009 | 9,309 |
| Of which in other currencies | 8,492 | 9,195 |
NOTE 11 – OTHER CURRENT LIABILITIES
The Group's other current liabilities broke down as follows at the period-end:
| In thousands of euros | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|
| Tax and social security liabilities | 34,941 | 32,543 |
| Other payables | 5,848 | 7,683 |
| Deferred income | 6,704 | 7,107 |
| TOTAL | 47,494 | 47,333 |
{24}------------------------------------------------
NOTE 12 – SEGMENT REPORTING
In accordance with IFRS 8, the Group reports segment information below in a manner consistent with the internal reporting used by its chief operating decision‑maker and Jérôme Bruhat, Chief Executive Officer of the Robertet Group.
The Group's operating segments as defined under IFRS correspond to its business. Internal reporting to the chief operating decision-maker and Executive Management is based on the following four operating segments, referred to internally as "Divisions":
- Raw Materials
- Fragrances
- Flavors
- Health & Beauty
| At June 30, 2025 | Total | Raw Materials | Fragrances | Flavors | Health & Beauty |
|---|---|---|---|---|---|
| Consolidated revenue | 446,337 | 117,294 | 159,741 | 157,659 | 11,643 |
| Recurring EBITDA | 100,222 | 24,818 | 28,549 | 45,556 | 1,300 |
| Recurring operating income | 85,187 | 20,375 | 24,556 | 39,331 | 924 |
| Net income attributable to owners of the Company |
58,501 | 12,759 | 17,903 | 28,061 | (222) |
| Goodwill | 82,290 | 22,669 | 17,808 | 37,424 | 4,389 |
| Property, plant and equipment and right-of-use assets |
195,658 | 58,247 | 54,494 | 78,799 | 4,119 |
| At June 30, 2024 | Total | Raw Materials | Fragrances | Flavors | Health & Beauty |
|---|---|---|---|---|---|
| Consolidated revenue | 414,579 | 102,554 | 158,918 | 142,436 | 10,671 |
| Recurring EBITDA | 88,919 | 14,347 | 39,289 | 32,065 | 3,218 |
| Recurring operating income | 72,808 | 10,577 | 32,971 | 26,439 | 2,820 |
| Net income attributable to owners of the Company |
51,688 | 6,497 | 23,904 | 19,213 | 2,074 |
| Goodwill | 81,710 | 22,089 | 17,808 | 37,424 | 4,389 |
| Property, plant and equipment and right-of-use assets |
183,162 | 38,530 | 77,717 | 62,790 | 4,124 |
| At December 31, 2024 | Total | Raw Materials | Fragrances | Flavors | Health & Beauty |
|---|---|---|---|---|---|
| Consolidated revenue | 807,609 | 195,823 | 318,368 | 272,253 | 21,166 |
| Recurring EBITDA | 157,066 | 24,937 | 70,004 | 58,959 | 3,165 |
| Recurring operating income | 125,256 | 13,485 | 62,532 | 46,850 | 2,388 |
| Net income attributable to owners of the Company |
90,068 | 7,524 | 47,081 | 34,182 | 1,281 |
| Goodwill | 83,154 | 23,534 | 17,808 | 37,424 | 4,389 |
| Property, plant and equipment and right-of-use assets |
201,137 | 57,336 | 60,059 | 79,982 | 3,760 |
{25}------------------------------------------------
NOTE 13 – DEPRECIATION, AMORTIZATION AND PROVISIONS
| In thousands of euros | June 30, 2024 | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|---|
| Amortization and depreciation of non-current assets | 13,678 | 27,933 | 14,590 |
| Additions to and reversals of provisions1 | 2,346 | 3,759 | 357 |
| TOTAL | 16,024 | 31,692 | 14,947 |
1 Additions to and reversals of provisions relate to receivables, inventories and provisions for contingencies and charges (see notes 6, 7 and 9).
NOTE 14 – OTHER OPERATING INCOME AND EXPENSES
| In thousands of euros | June 30, 2024 | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|---|
| Capitalized production | - | 21 | 18 |
| Operating subsidies | 866 | 2,413 | 852 |
| Other operating income | 2,893 | 2,175 | 2,250 |
| Other non-recurring income | 29 | 212 | 96 |
| TOTAL OTHER OPERATING INCOME | 3,788 | 4,820 | 3,216 |
| Other non-recurring expenses | (86) | (117) | (88) |
| TOTAL OTHER OPERATING EXPENSES | (86) | (117) | (88) |
The liability relating to the earn-out clause applied to the acquisition of the Maverick group (Omega Ingredients) (see note 10.1) of which the Robertet Group took control in 2022, has been remeasured in light of the subgroup's operating performance, which was lower than expected for the period from September 1, 2024 to August 31, 2025, and the downward revision of the projected operating performance assumptions for the period from September 1, 2025 to August 31, 2026. The impact of the remeasurement of this liability was recognized in other operating income in the amount of €1,286 thousand.
NOTE 15 – FINANCIAL INCOME AND EXPENSES
| In thousands of euros | June 30, 2024 | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|---|
| Interest on borrowings and similar expenses | (6,432) | (11,350) | (4,749) |
| Income from marketable securities | 2,914 | 5,649 | 2,410 |
| Net finance costs | (3,519) | (5,701) | (2,339) |
| Foreign exchange losses | (1,538) | (1,590) | (6,893) |
| Foreign exchange gains | 2,181 | 5,995 | 4,353 |
| Other | (1,345) | (3,055) | (814) |
| Other financial income and expenses | (702) | 1351 | (3,354) |
| TOTAL | (4,221) | (4,350) | (5,693) |
{26}------------------------------------------------
NOTE 16 – INCOME TAX
The tax charge for the period is calculated by applying the estimated average effective tax rate to pre-tax income. This calculation is carried out individually for each of the Group's consolidated tax entities.
| June 30, 2024 | June 30, 2025 | |||
|---|---|---|---|---|
| In thousands of euros | Net income before taxes |
Net income tax benefit/(expense) |
Net income before taxes |
Net income tax benefit/(expense) |
| French companies of the Group | 25,832 | (6,924) | 30,491 | (9,308) |
| Other Group companies | 42,999 | (9,983) | 48,954 | (11,435) |
| TOTAL | 68,831 | (16,907) | 79,445 | (20,743) |
| In thousands of euros | June 30, 2024 | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|---|
| Current tax | (18,031) | (37,916) | (19,376) |
| Net deferred tax | 1,124 | 7,371 | (1,367) |
| INCOME TAX | (16,907) | (30,545) | (20,743) |
Deferred tax assets and liabilities can be analyzed as follows:
| In thousands of euros | Dec. 31, 2024 | June 30, 2025 | Change |
|---|---|---|---|
| Deferred tax assets | 6,744 | 5,730 | (1,014) |
| Deferred tax liabilities | 25,847 | 26,709 | 863 |
| Net deferred tax | (19,103) | (20,979) | (1,877) |
| In thousands of euros | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|
| Net deferred taxes at January 1: assets/(liabilities) |
(27,040) | (19,103) |
| Recognized in equity | 726 | (86) |
| Changes in scope of consolidation | 52 | |
| (Expense)/benefit | 7,371 | (1,367) |
| Translation adjustments | (212) | (423) |
| TOTAL | (19,103) | (20,979) |
| Of which deferred tax liabilities | 25,847 | 26,709 |
| Of which deferred tax assets | 6,744 | 5,730 |
{27}------------------------------------------------
NOTE 17 – CASH AND CASH EQUIVALENTS
| Net cash and cash equivalents (in thousands of euros) | June 30, 2024 | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|---|
| Cash and cash equivalents | 97,162 | 72,543 | 76,833 |
| Marketable securities | 64,460 | 85,591 | 69,804 |
| Bank overdrafts | (7,373) | (2,223) | (3,666) |
| TOTAL | 154,249 | 155,910 | 142,970 |
Working capital requirement at the reporting date breaks down as follows:
| Analysis of change in working capital (in thousands of euros) |
Dec. 31, 2024 | Changes in exchange rates and other |
Cash flow | June 30, 2025 |
|---|---|---|---|---|
| Inventories and work in progress | 247,618 | (11,705) | 9,883 | 245,795 |
| Trade and other receivables | 188,958 | (7,105) | 36,521 | 218,374 |
| Trade and other payables | (110,361) | 5,111 | (9,524) | (114,774) |
| GROSS WORKING CAPITAL REQUIREMENT |
326,214 | (13,699) | 36,880 | 349,395 |
| Impairment | (17,798) | 191 | (381) | (17,988) |
| NET WORKING CAPITAL REQUIREMENT | 308,417 | (13,508) | 36,499 | 331,407 |
Marketable securities consist of certificates of deposit and other short-term investments, liquid investments and maturities of less than three months:
| In thousands of euros | Dec. 31, 2024 | Movements | Translation adjustments |
June 30, 2025 |
|---|---|---|---|---|
| Marketable securities | 85,591 | (11,370) | (4,417) | 69,804 |
NOTE 18 – EARNINGS PER SHARE
The calculation of basic and diluted earnings per share at June 30, 2024, December 31, 2024 and June 30, 2025 is presented below:
| Basic earnings | June 30, 2024 | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|---|
| Net income attributable to owners of the Company (in thousands of euros) | 51,688 | 90,068 | 58,501 |
| Weighted average number of ordinary shares and investment certificates outstanding (in thousands) |
2,092 | 2,092 | 2,049 |
| BASIC EARNINGS PER SHARE (IN EUROS) | 24.71 | 43.06 | 28.55 |
{28}------------------------------------------------
| Diluted earnings | June 30, 2024 | Dec. 31, 2024 | June 30, 2025 |
|---|---|---|---|
| Net income attributable to owners of the Company (in thousands of euros) | 51,688 | 90,068 | 58,501 |
| Weighted average number of ordinary shares and investment certificates outstanding (in thousands) |
2,092 | 2,092 | 2,049 |
| Weighted average number of shares taken into account for the calculation of diluted earnings per share (in thousands) |
2092 | 2,092 | 2,049 |
| DILUTED EARNINGS PER SHARE (IN EUROS) |
24.71 | 43.06 | 28.55 |
An investment certificate corresponds to a portion of the Company's capital that does not carry voting rights.
NOTE 19 – INFORMATION ON TRANSACTIONS WITH RELATED PARTIES
Transactions with affiliated companies solely correspond to purchases/sales of raw materials by the parent company from/to those companies. Transactions in the first half of the year represented purchases of €4,883 thousand and sales of €115 thousand, compared with purchases of €1,233 thousand and sales of €25 thousand in first-half 2024.
In addition, four free share plans were set up, authorized by the Board of Directors on April 11, 2025 and June 5, 2025:
| Plan date | Number of shares |
Vesting conditions | Vesting date | Availability date |
|---|---|---|---|---|
| April 11, 2025 | 700 | Free shares – not subject to performance conditions | April 11, 2026 | April 11, 2028 |
| April 11, 2025 | 720 | Free shares – subject to performance conditions | April 11, 2028 | April 11, 2030 |
| June 5, 2025 | 307 | Free shares – not subject to performance conditions | June 5, 2026 | June 5, 2028 |
| June 5, 2025 | 797 | Free shares – subject to performance conditions | June 5, 2028 | June 5, 2030 |
In addition, some of the free shares allocated in June 2022 and June 2024 vested during the period:
| Plan date | Number of shares |
Vesting conditions | Vesting date | Availability date |
|---|---|---|---|---|
| June 12, 2024 | 964 | Free shares – not subject to performance conditions | June 12, 2025 | June 12, 2027 |
| June 14, 2022 | 785 | Free shares – subject to performance conditions | June 14, 2025 | June 14, 2027 |
The IFRS 2 expense resulting from these plans recognized in first-half 2025 amounted to €1,056 thousand, compared with €1,314 thousand in first-half 2024.
See note 24 to the 2024 Annual Financial Report for more information on compensation.
NOTE 20 – SEASONALITY
The Group's business is not highly seasonal. However, the contribution of the first half to annual revenue is, as usual, slightly higher than that of the second half.
{29}------------------------------------------------
NOTE 21 – LIST OF CONSOLIDATED COMPANIES
| Company | Country | % control | Consolidation method |
|---|---|---|---|
| Robertet SA | France | Parent company | |
| Robertet South Africa Aromatics Pty Ltd | South Africa | 100% | |
| Robertet GmbH | Germany | 100% | |
| Robertet Argentina S.A.I.C | Argentina | 100% | |
| Robertet do Brasil Indústria e Comércio Ltda | Brazil | 100% | |
| Robertet Bulgaria EOOD | Bulgaria | 100% | |
| Robertet (Shanghai) International Trading Co. Ltd | China | 100% | |
| Robertet Flavors & Fragrances (Beijing) Co. Ltd | China | 100% | |
| Robertet Andina S.A.S | Colombia | 100% | |
| Robertet Korea Ltd | South Korea | 100% | |
| Robertet Middle East FZ LLD | United Arab Emirates | 100% | |
| Aroma Esencial S.L. | Spain | 100% | |
| Robertet España S.A. | Spain | 100% | |
| Robertet USA Inc. | United States | 100% | |
| Robertet Inc. | United States | 100% | D |
| Robertet Flavors Inc. | United States | 100% | E |
| Robertet Fragrances Creative Center Inc. | United States | 100% | T A |
| Phasex Corporation | United States | 100% | D LI |
| Robertet Canada Inc. | Canada | 100% | O |
| Astier Demarest SAS | France | 90% | S N |
| Bionov SARL | France | 100% | O |
| Robertet Bio SAS | France | 100% | C Y |
| Sirius SAS | France | 100% | L |
| Villa Blu SAS | France | 100% | L U |
| Robertet Flavours & Fragrances India Pvt. Ltd | India | 100% | F |
| Robertet India Private Ltd | India | 100% | |
| Sonarome Private Ltd | India | 85% | |
| PT Robertet Group Indonesia | Indonesia | 100% | |
| Robertet Italia S.r.l | Italy | 100% | |
| Robertet Japan Ltd | Japan | 100% | |
| Robertet de Mexico S.A. de C.V | Mexico | 100% | |
| Robertet UK Limited Ltd | United Kingdom | 100% | |
| Maverick Active Holding Ltd | United Kingdom | 100% | |
| Omega Ingredients Ltd | United Kingdom | 100% | |
| Omega Corp | United States | 100% | |
| Robertet Asia Pte Ltd | Singapore | 100% | |
| Robertet SA | Switzerland | 100% | |
| Robertet Gülyaği VE Itriyat Sanayi Ltd Şti. | Turkey | 100% | |
| Hitex SAS | France | 50% | Accounted for by the equity method |
{30}------------------------------------------------
STATUTORY AUDITORS' REVIEW REPORT ON THE HALF-YEARLY FINANCIAL INFORMATION
For the period from January 1 to June 30, 2025

{31}------------------------------------------------
STATUTORY AUDITORS' REVIEW REPORT ON THE HALF-YEARLY FINANCIAL INFORMATION 2025
ROBERTET S.A.
For the period from January 1 to June 30, 2025
This is a free translation into English of the statutory auditors' review report on the half-yearly financial information issued in French and is provided solely for the convenience of English-speaking users. This report includes information relating to the specific verification of information given in the Group's half-yearly management report. This report should be read in conjunction with, and construed in accordance with, French law and professional standards applicable in France.
Robertet S.A. 37 Avenue Sidi Brahim 06130 Grasse Cedex
To the Shareholders,
In compliance with the assignment entrusted to us by your General Meeting and in accordance with the requirements of article L. 451-1-2 III of the French Monetary and Financial Code ("Code monétaire et financier"), we hereby report to you on:
- the review of the accompanying condensed half-yearly consolidated financial statements of Robertet S.A., for the period from January 1, 2025 to June 30, 2025;
- the verification of the information presented in the half-yearly management report.
These condensed half-yearly consolidated financial statements are the responsibility of the Board of Directors. Our role is to express a conclusion on these financial statements based on our review.
I - CONCLUSION ON THE FINANCIAL STATEMENTS
We conducted our review in accordance with professional standards applicable in France.
A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with professional standards applicable in France and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Based on our review, nothing has come to our attention that causes us to believe that the accompanying condensed half-yearly consolidated financial statements are not prepared, in all material respects, in accordance with IAS 34 standard of the IFRSs as adopted by the European Union applicable to interim financial information.
II. SPECIFIC VERIFICATION
We have also verified the information presented in the half-yearly management report on the condensed halfyearly consolidated financial statements subject to our review.
We have no matters to report as to its fair presentation and consistency with the condensed half-yearly consolidated financial statements.
The statutory auditors
Marseille, Lyon,
17 September 2025 KPMG S.A. 17 September 2025 COGEPARC S.A.
Loïc Herrmann Anne Brion Turck
Partner Partner
COGEPARC S.A. ROBERTET S.A.
KPMG S.A.
{32}------------------------------------------------
STATEMENT BY THE PERSONS RESPONSIBLE FOR THE INTERIM FINANCIAL REPORT
For the period from January 1, 2025 to June 30, 2025

{33}------------------------------------------------

PHILIPPE MAUBERT Chairman of the Board of Directors
JÉRÔME BRUHAT Chief Executive Officer
Grasse, September 10, 2025
STATEMENT BY THE PERSONS RESPONSIBLE FOR THE 2025 INTERIM FINANCIAL REPORT
We certify that, to the best of our knowledge, the half-yearly consolidated financial statements have been prepared in accordance with the applicable accounting standards and give a true and fair view of the assets, liabilities, financial position and profit or loss of the company and of all the companies included in the scope of consolidation, and that the interim management report attached hereto gives a true and fair view of significant events over the first six months of the year, the impact on the financial statements, the main transactions with related parties and a description of the main risks and uncertainties for the remaining six months of the year.
{34}------------------------------------------------

{35}------------------------------------------------
